A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients

BMC Gastroenterology

Volumn 14, Issue 1, 2014, Pages

  Saner, Fuat H ^a   Nowak, Knut ^a   Hoyer, Dieter ^a   Rath, Peter ^a   Canbay, Ali ^a   Paul, Andreas ^a   Koldehoff, Michael ^a   Elmaaǧacli, Ahmet ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SULTAMICILLIN; TACROLIMUS; TOLL LIKE RECEPTOR 4; VALGANCICLOVIR;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIALYSIS; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; GENE MUTATION; GENETIC ASSOCIATION; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; INCIDENCE; INTERVENTION STUDY; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRAFT; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MORTALITY; NOD2 GENE; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; TLR 4 GENE;

ADULT; HUMANS; INCIDENCE; INFECTION; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; MIDDLE AGED; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY; SURVIVAL RATE;

EID: 84891547184     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-14-4     Document Type: Article

References (34)

1. Blair JE, Kusne S. Bacterial, mycobacterial, and protozoal infections after liver transplantation-part I. Liver Transpl 2005, 11(12):1452-1459. 10.1002/lt.20624, 16315310.
2. Saner FH, Olde Damink SW, Pavlakovic G, van den Broek MA, Rath PM, Sotiropoulos GC, Radtke A, Canbay A, Paul A, Nadalin S, et al. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation 2008, 85(11):1564-1568. 10.1097/TP.0b013e31816f61a6, 18551060.
3. Ergin F, Arslan H, Azap A, Demirhan B, Karakayali H, Haberal M. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature. Transpl Int 2003, 16(4):280-286. 10.1111/j.1432-2277.2003.tb00300.x, 12730810.
4. Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, Jacobs R, Dominguez EA, Tollemar JG, Baumgarten K, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-aspergillus mycelial fungi. Clin Infect Dis 2003, 37(2):221-229. 10.1086/375822, 12856215.
5. van den Broek MA, Damink SW, Winkens B, Broelsch CE, Malago M, Paul A, Saner FH. Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit. Liver Transpl 2010, 16(3):402-410. 10.1002/lt.21987, 20209599.
6. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Deviere J, et al. Deficient host-bacteria interactions in inflammatory bowel disease? the toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004, 53(7):987-992. 10.1136/gut.2003.030205, 1774122, 15194649.
7. Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R, Ottinger H, Rath PM, Ross RS, Roggendorf M, et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006, 81(2):247-254. 10.1097/01.tp.0000188671.94646.16, 16436969.
8. Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW, Berger SP, Daha MR, Frolich M, van der Slik AR, et al. Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 2005, 129(2):408-414.
9. Worthley DL, Johnson DF, Eisen DP, Dean MM, Heatley SL, Tung JP, Scott J, Padbury RT, Harley HA, Bardy PG, et al. Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis 2009, 48(4):410-417. 10.1086/596313, 19143554.
10. Eurich D, Boas-Knoop S, Morawietz L, Neuhaus R, Somasundaram R, Ruehl M, Neumann UP, Neuhaus P, Bahra M, Seehofer D. Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma. Liver Int 2011, 31(7):1006-1012. 10.1111/j.1478-3231.2011.02522.x, 21733090.
11. Eid AJ, Brown RA, Paya CV, Razonable RR. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation 2007, 84(4):511-516. 10.1097/01.tp.0000276960.35313.bf, 17713436.
12. Ningappa M, Higgs BW, Weeks DE, Ashokkumar C, Duerr RH, Sun Q, Soltys KA, Bond GJ, Abu-Elmagd K, Mazariegos GV, et al. NOD2 gene polymorphism rs2066844 associates with need for combined liver-intestine transplantation in children with short-gut syndrome. Am J Gastroenterol 2011, 106(1):157-165. 10.1038/ajg.2010.322, 20959815.
13. de Mare-Bredemeijer EL, Mancham S, Utomo WK, de C, van Thielen M, de Meester E, Rossau R, van der Laan LJ, Hansen BE, Tilanus HW, et al. Genetic polymorphisms in innate immunity receptors do not predict the risk of bacterial and fungal infections and acute rejection after liver transplantation. Transpl Infect Dis 2012, 15(2):120-133.
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16(3):128-140. 10.1016/0196-6553(88)90053-3, 2841893.
15. Olthoff KM, Kulik L, Samstein B, Kaminski M, Abecassis M, Emond J, Shaked A, Christie JD. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010, 16(8):943-949. 10.1002/lt.22091, 20677285.
16. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006, 6(4):783-790. 10.1111/j.1600-6143.2006.01242.x, 16539636.
17. Elmaagacli AH, Steckel N, Ditschkowski M, Hegerfeldt Y, Ottinger H, Trenschel R, Koldehoff M, Beelen DW. Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors. Bone Marrow Transplant 2011, 46(5):702-708. 10.1038/bmt.2010.166, 20622911.
18. Elmaagacli AH, Koldehoff M, Beelen DW. Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9. Bone Marrow Transplant 2009, 44(5):295-302. 10.1038/bmt.2009.32, 19252531.
19. Heise M, Settmacher U, Pfitzmann R, Wunscher U, Muller AR, Jonas S, Neuhaus P. A survival-based scoring-system for initial graft function following orthotopic liver transplantation. Transpl Int 2003, 16(11):794-800. 10.1111/j.1432-2277.2003.tb00243.x, 12844216.
20. Gonzalez FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J, Lacy AM, Cugat E, Visa J, Rodes J. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994, 20(3):565-573.
21. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome: national institute of diabetes and digestive and kidney diseases liver transplantation database. Transplantation 1998, 66(3):302-310. 10.1097/00007890-199808150-00005, 9721797.
22. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J, Eissner G, Scholmerich J, Andreesen R. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004, 104(3):889-894. 10.1182/blood-2003-10-3543, 15090455.
23. Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Platz KP, Keck H. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg 1994, 219(4):426-434. 10.1097/00000658-199404000-00014, 1243160, 8161269.
24. O'Connor TP, Lewis WD, Jenkins RL. Biliary tract complications after liver transplantation. Arch Surg 1995, 130(3):312-317. 10.1001/archsurg.1995.01430030082017, 7887800.
25. Corno V, Colledan M, Dezza MC, Guizzetti M, Lucianetti A, Maldini G, Pinelli D, Giovanelli M, Zambelli M, Torre G, et al. Extended right split liver graft for primary transplantation in children and adults. Transpl Int 2006, 19(6):492-499. 10.1111/j.1432-2277.2006.00323.x, 16771871.
26. Avkan-Oguz V, Ozkardesler S, Unek T, Ozbilgin M, Akan M, Firuzan E, Kose H, Astarcioglu I, Karademir S. Risk factors for early bacterial infections in liver transplantation. Transplant Proc 2013, 45(3):993-997. 10.1016/j.transproceed.2013.02.067, 23622606.
27. Sganga G, Spanu T, Bianco G, Fiori B, Nure E, Pepe G, D'Inzeo T, Lirosi MC, Frongillo F, Agnes S. Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles. Transplant Proc 2012, 44(7):1973-1976. 10.1016/j.transproceed.2012.06.055, 22974885.
28. Sun HY, Cacciarelli TV, Singh N. Identifying a targeted population at high risk for infections after liver transplantation in the MELD era. Clin Transplant 2011, 25(3):420-425. 10.1111/j.1399-0012.2010.01262.x, 20482564.
29. Schlitt HJ, Loss M, Scherer MN, Becker T, Jauch KW, Nashan B, Schmidt H, Settmacher U, Rogiers X, Neuhaus P, et al. Current developments in liver transplantation in Germany: MELD-based organ allocation and incentives for transplant centres. Z Gastroenterol 2011, 49(1):30-38. 10.1055/s-0029-1245946, 21225535.
30. Markmann JF, Markmann JW, Markmann DA, Bacquerizo A, Singer J, Holt CD, Gornbein J, Yersiz H, Morrissey M, Lerner SM, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001, 72(6):1113-1122. 10.1097/00007890-200109270-00023, 11579310.
31. Brown RS, Lombardero M, Lake JR. Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation. Transplantation 1996, 62(12):1788-1793. 10.1097/00007890-199612270-00018, 8990364.
32. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?. Am J Transplant 2006, 6(11):2651-2659. 10.1111/j.1600-6143.2006.01526.x, 16939515.
33. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002, 35(5):1179-1185. 10.1053/jhep.2002.33160, 11981768.
34. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, Wiesner RH. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004, 4(5):819-825. 10.1111/j.1600-6143.2004.00433.x, 15084180.